Fisetin suppresses ferroptosis through Nrf2 and attenuates intervertebral disc degeneration in rats

Eur J Pharmacol. 2024 Feb 5:964:176298. doi: 10.1016/j.ejphar.2023.176298. Epub 2023 Dec 23.

Abstract

Low back pain, primarily caused by intervertebral disc degeneration (IVDD), lacks effective pharmacological treatments. Oxidative stress has been identified as a significant contributor to IVDD. This study aims to establish an in vitro model of IVDD induced by oxidative stress and identify potential therapeutic agents and their underlying mechanisms. By screening the natural product library, fisetin emerged as the most promising compound in suppressing cell death induced by oxidative stress in nucleus pulposus cells (NPCs). Furthermore, our investigation revealed that the cell death induced by oxidative stress was predominantly associated with ferroptosis, and fisetin demonstrated the ability to inhibit ferroptosis in NPCs. Mechanistic exploration suggested that the impact of fisetin on ferroptosis may be mediated through the Nrf2/HO-1 (Nuclear factor erythroid 2-related factor 2/heme oxygenase-1) axis. Notably, the in vivo study demonstrated that fisetin could alleviate IVDD in rats. These findings highlight fisetin as a potential therapeutic option for IVDD and implicate the involvement of the Nrf2/HO-1 pathway in its mechanism of action.

Keywords: Fisetin; IVDD; Nrf2; Oxidative stress.

MeSH terms

  • Animals
  • Ferroptosis* / drug effects
  • Flavonols* / pharmacology
  • Flavonols* / therapeutic use
  • Intervertebral Disc Degeneration* / drug therapy
  • NF-E2-Related Factor 2 / metabolism
  • Rats

Substances

  • fisetin
  • Flavonols
  • NF-E2-Related Factor 2